PT Hetzer Medical Indonesia Tbk (IDX:MEDS)
Indonesia · Delayed Price · Currency is IDR 74.00
-1.00 (-1.33%)
Sep 2, 2026, 1:39 PM WIB
IDX:MEDS Financials Overview
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 15,011 | 6,629 | 6,391 | 22,723 | 37,737 | 75,790 |
Revenue Growth | 265.88% | 3.72% | -71.88% | -39.79% | -50.21% | -13.67% |
Gross Profit Gross Profit Growth | 4,731 | 368.02 | 525.3 | 10,637 | 21,025 | 53,978 |
Operating Income Operating Income Growth | -4,024 | -8,270 | -8,674 | -2,603 | 4,553 | 34,064 |
Net Income Net Income Growth | -4,156 | -8,346 | -8,534 | -3,570 | 237.06 | 26,631 |
Earnings Per Share EPS Growth | -2.66 | -5.34 | -5.46 | -2.29 | 0.17 | 21.31 |
EPS Growth | - | - | - | - | -99.19% | -29.85% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Mask Mask Growth | 2,899 | 2,061 | 3,081 | 4,355 | 11,278 |
Others Others Growth | 7.35 | 2.51 | 15.81 | 84.32 | 195.11 |
Tensimeter Tensimeter Growth | 165.5 | 384.16 | 4,027 | - | - |
Bouffant Cap Bouffant Cap Growth | 749.21 | 268.92 | 352.88 | 482.42 | 715.9 |
Mask plus Mask plus Growth | 2,446 | 3,233 | 12,740 | 32,816 | 63,601 |
Stethoscope Stethoscope Growth | 361.92 | 441.02 | 2,506 | - | - |
Total Total Growth | 6,629 | 6,391 | 22,723 | 37,737 | 75,790 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 252.69 | 779.02 | 232.09 | 665.57 | 5,362 | 1,401 |
Total Debt Total Debt Growth | 6,206 | 8,000 | 5,194 | 7,991 | 10,035 | 11,288 |
Net Cash (Debt) Net Cash Growth | -5,953 | -7,221 | -4,962 | -7,326 | -4,673 | -9,887 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.81 | -4.62 | -3.18 | -4.69 | -3.40 | -7.91 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -727.01 | -1,475 | 2,230 | 3,152 | -13,023 | 13,484 |
Capital Expenditures CapEx Growth | -2,998 | -1,256 | -275.84 | -6,084 | -17,971 | -27,008 |
Free Cash Flow Free Cash Flow Growth | -3,725 | -2,731 | 1,954 | -2,932 | -30,995 | -13,524 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.52% | 5.55% | 8.22% | 46.81% | 55.71% | 71.22% |
Operating Margin | -26.81% | -124.76% | -135.72% | -11.46% | 12.07% | 44.95% |
Pretax Margin | -29.16% | -129.25% | -129.46% | -15.79% | 1.58% | 45.03% |
Profit Margin | -27.68% | -125.90% | -133.52% | -15.71% | 0.63% | 35.14% |
FCF Margin | -24.82% | -41.20% | 30.58% | -12.90% | -82.13% | -17.84% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 883.21 | - |
P/FCF Ratio | - | - | 39.98 | - | - | - |
PS Ratio | 7.81 | 16.74 | 12.22 | 4.68 | 5.55 | - |